NOBEL MEDICUS, vol.7, no.1, pp.84-87, 2011 (SCI-Expanded)
Objective: Antiproliferative effectiveness of nonsteroidal anti-inflammatoty drugs (NSAID) has been shown on colon, esophagus, stomach carcinoma, and CML cell lines in several experimental studies. In this study, effects of 100 and 200 mu M/L indomethacin doses, an indol-derived nonselective NSAID, on hepatocellular cancer cell line (Hep G2) were investigated.